Epigral Limited
Epigral Limited is an Indian listed company in the Chemicals & Petrochemicals industry (Commodities sector), traded under NSE: EPIGRAL and BSE: 543332 (ISIN INE071N01016).
It has a market capitalisation of ₹4,232 crore, a last close of ₹980.90 on 2026-10-19, a one-year return of -42.3%.
Valuation: a price-to-earnings ratio of 15.61x, a price-to-book ratio of 1.90x, a dividend yield of 0.5%.
Profitability: return on equity of 16.1%, return on capital employed of 15.2%, an operating margin of 22.2%.
Growth: sales growth of 4.9% a year over three years, net profit growth of -2.1% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.25x, promoter holding of 68.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 4,232 |
| Last close | ₹980.90 |
| P/E (TTM) | 15.61x |
| P/B | 1.90x |
| Dividend yield | 0.5% |
| ROE (FY) | 16.1% |
| ROCE (FY) | 15.2% |
| Operating margin (TTM) | 22.2% |
| Sales growth, 3-year CAGR | 4.9% |
| Profit growth, 3-year CAGR | -2.1% |
| Debt / equity | 0.25x |
| Promoter holding | 68.8% |
| 1-year return | -42.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means
